Drug Topics’ legal compliance columnist named partner in Roetzel's Chicago office and head of the firm’s Drug and Pharmacy practice.
Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.
Sandoz has announced the U.S. launch of an authorized generic version of PharmaDerm’s Solaraze Gel (diclofenac 3% gel), which generated $92 million in 2012.
This new treatment option copackages 3 drugs for optimal treatment.
Healthcare execs need to lay the cultural foundation today for upcoming technology changes
The FDA approved imetelstat (Rytelo) in June 2024.
Reevaluation of RECORD trial data fails to uncover elevated cardiovascular risk.
When it comes to knowledge of medications and their actions, pharmacists have it way over most physicians. For the sake of the patient, you have to speak up, whether the doc likes it or not.
Asking whether hydrocodone should be rescheduled is only the beginning.
If your inner entrepreneur is hollering to get out, maybe you should go for it.
The legalization of marijuana has consequences.
Female pharmacists make up approximately 62% of the pharmacy workforce. They want, and in many cases demand, a good work-life balance.
Specialty pharmaceuticals will have a growing impact on pharmacists. Here’s how it could change your role.
Your patients are using herbal products, but do you know enough about them?
How can an independent pharmacy survive in the face of competition from the mega-chains? Here's a clue.
This year may mark a dramatic difference in the development and approval of complex generic drug products.
FDA approves apalutamide for castration-resistant prostate cancer.
FDA approves apalutamide for castration-resistant prostate cancer.
Could telemedicine be the answer to diabetes management problems?
Technology can help patients who need specialty pharmacy medications get them faster by streamlining the processes involved.
Pharmacists urged to support controls to the marijuana market but oppose criminalization.
Board-certified pharmacists are better prepared to deal with pediatric patients than others. Here’s why.
Betrixaban has been approved by the FDA for patients at risk for thromboembolisms.
Betrixaban has been approved by the FDA for patients at risk for thromboembolisms.
How independent pharmacies can use specialty medications to increase profits and help their patients.
President Biden’s recent State of the Union address included a pharmacy Test to Treat iniativie for COVID-19.
NCPA found three things that pharmacists desperately want changed. Here’s how they’re going to do it.
Healthcare is at a dangerous place right now-but pharmacists can be the ones to help save it.
If you’ve never thought about becoming certified, now is a great time to do it.